Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Campora

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Minerva Medica|January 1, 1994
[Tropisetron versus ondansetron in the prevention and control of emesis in patients undergoing chemotherapy with FAC/FEC for metastatic or surgically treated breast carcinoma]E Campora, C Simoni, R Rosso
Plastic and Reconstructive Surgery|April 1, 1987
Postquadrantectomy breast deformities: classification and techniques of surgical correctionP Berrino, E Campora, P Santi
Journal of Economic Entomology|October 30, 2001
Tunnel orientation and search pattern sequence of the formosan subterranean termite (Isoptera: Rhinotermitidae)C E Campora, J K Grace
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
Ondansetron for the control of dacarbazine-induced emesisE Campora, S Chiara, C Aschele
Plastic and Reconstructive Surgery|August 1, 1993
Reconstruction of the radiated partial mastectomy defect with autogenous tissuesP Berrino, E Campora, P Santi
Plastic and Reconstructive Surgery|November 1, 1992
Correction of type II breast deformities following conservative cancer surgeryP Berrino, E Campora, S Leone, et al.
Journal of Clinical Laboratory Analysis|May 25, 2006
Comparative analysis of purified Pacific and Caribbean ciguatoxin congeners and related marine toxins using a modified ELISA techniqueCara E Campora, Y Hokama, Joanne S M Ebesu
Giornale Italiano Di Chemioterapia|January 1, 1985
[Treatment of advanced stage gastric carcinoma: FAM versus chemotherapeutic regimens excluding adriamycin]L Repetto, E Campora, M T Nobile, et al.
Tumori|October 31, 1981
Epiglottic non-Hodgkin's lymphoma: case reportE Mora, M R Sertoli, E Campora, et al.
Oncology|January 1, 1991
Control of refractory, chemotherapy-induced emesis with the serotonin antagonist ondansetron (GR38032F)E Campora, G Vidili, C Oliva, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Minerva Medica|January 1, 1994
[Tropisetron versus ondansetron in the prevention and control of emesis in patients undergoing chemotherapy with FAC/FEC for metastatic or surgically treated breast carcinoma]E Campora, C Simoni, R Rosso
Plastic and Reconstructive Surgery|April 1, 1987
Postquadrantectomy breast deformities: classification and techniques of surgical correctionP Berrino, E Campora, P Santi
Journal of Economic Entomology|October 30, 2001
Tunnel orientation and search pattern sequence of the formosan subterranean termite (Isoptera: Rhinotermitidae)C E Campora, J K Grace
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
Ondansetron for the control of dacarbazine-induced emesisE Campora, S Chiara, C Aschele
Plastic and Reconstructive Surgery|August 1, 1993
Reconstruction of the radiated partial mastectomy defect with autogenous tissuesP Berrino, E Campora, P Santi
Plastic and Reconstructive Surgery|November 1, 1992
Correction of type II breast deformities following conservative cancer surgeryP Berrino, E Campora, S Leone, et al.
Journal of Clinical Laboratory Analysis|May 25, 2006
Comparative analysis of purified Pacific and Caribbean ciguatoxin congeners and related marine toxins using a modified ELISA techniqueCara E Campora, Y Hokama, Joanne S M Ebesu
Giornale Italiano Di Chemioterapia|January 1, 1985
[Treatment of advanced stage gastric carcinoma: FAM versus chemotherapeutic regimens excluding adriamycin]L Repetto, E Campora, M T Nobile, et al.
Tumori|October 31, 1981
Epiglottic non-Hodgkin's lymphoma: case reportE Mora, M R Sertoli, E Campora, et al.
Oncology|January 1, 1991
Control of refractory, chemotherapy-induced emesis with the serotonin antagonist ondansetron (GR38032F)E Campora, G Vidili, C Oliva, et al.
Pageof 8